VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,837 | -10.6% | 700 | 0.0% | 0.01% | -7.1% |
Q2 2023 | $21,077 | -6.9% | 700 | 0.0% | 0.01% | -12.5% |
Q1 2023 | $22,645 | +12.9% | 700 | 0.0% | 0.02% | +6.7% |
Q4 2022 | $20,062 | +18.0% | 700 | 0.0% | 0.02% | +7.1% |
Q3 2022 | $17,000 | -10.5% | 700 | 0.0% | 0.01% | 0.0% |
Q2 2022 | $19,000 | -29.6% | 700 | 0.0% | 0.01% | -17.6% |
Q1 2022 | $27,000 | +22.7% | 700 | 0.0% | 0.02% | +30.8% |
Q4 2021 | $22,000 | +4.8% | 700 | 0.0% | 0.01% | -7.1% |
Q3 2021 | $21,000 | -12.5% | 700 | 0.0% | 0.01% | -12.5% |
Q2 2021 | $24,000 | +4.3% | 700 | 0.0% | 0.02% | +23.1% |
Q1 2021 | $23,000 | -8.0% | 700 | 0.0% | 0.01% | -13.3% |
Q4 2020 | $25,000 | -51.0% | 700 | -46.2% | 0.02% | -54.5% |
Q3 2020 | $51,000 | +6.2% | 1,300 | 0.0% | 0.03% | 0.0% |
Q2 2020 | $48,000 | +60.0% | 1,300 | 0.0% | 0.03% | +32.0% |
Q1 2020 | $30,000 | -21.1% | 1,300 | 0.0% | 0.02% | 0.0% |
Q4 2019 | $38,000 | +8.6% | 1,300 | 0.0% | 0.02% | 0.0% |
Q3 2019 | $35,000 | +6.1% | 1,300 | 0.0% | 0.02% | -7.4% |
Q2 2019 | $33,000 | -29.8% | 1,300 | -38.4% | 0.03% | -28.9% |
Q1 2019 | $47,000 | – | 2,111 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |